2nd Clinic of Surgery, University of Debrecen, Debrecen, Hungary

A medical nutriment has supportive value in the treatment of colorectal cancer

Avemar (MSC) is a medical nutriment of which preclinical and observational clinical studies suggested an antimetastatic activity with no toxicity. This open-label cohort trial has compared anticancer treatments plus Avemar (9 g once daily) vs anticancer treatments alone in colorectal patients, enrolled from three oncosurgical centres; cohort allocation was on the basis of patients’ choice.

Search publications